Nymox Pharmaceutical
NYMX
#10168
Rank
NZ$31.26 M
Marketcap
Country
NZ$0.34
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.79 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.18 Million, an increase over its 2021 earnings that were of -NZ$21.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.79 Million-66.1%
2022 -NZ$11.18 Million-47.71%
2021 -NZ$21.38 Million6.61%
2020 -NZ$20.06 Million-10.91%
2019 -NZ$22.51 Million24.24%
2018 -NZ$18.12 Million-20.03%
2017 -NZ$22.66 Million2.71%
2016 -NZ$22.06 Million-63.86%
2015 -NZ$61.04 Million674.44%
2014 -NZ$7.89 Million-6.11%
2013 -NZ$8.4 Million-35.66%
2012 -NZ$13.05 Million-20.76%
2011 -NZ$16.47 Million38.33%
2010 -NZ$11.91 Million35.59%
2009 -NZ$8.78 Million11.8%
2008 -NZ$7.86 Million-12.94%
2007 -NZ$9.02 Million8.85%
2006 -NZ$8.29 Million36.5%
2005 -NZ$6.08 Million-4.4%
2004 -NZ$6.35 Million-14.58%
2003 -NZ$7.44 Million
2001 -NZ$5.46 Million-20.54%
2000 -NZ$6.87 Million21.72%
1999 -NZ$5.64 Million-25.56%
1998 -NZ$7.58 Million101.3%
1997 -NZ$3.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$13.93 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.30 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.20 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.54 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.49 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA